# Predictive value of the systemic immune-inflammation index combined with the prognostic nutritional index for postoperative recurrence in early-stage cervical cancer: evidence from a multicenter cohort study

**Authors:** Anihenimu Abudoukade, Shihao Hong, Min Jiang, Dong Yin, Burebi Maimaiti

PMC · DOI: 10.3389/fonc.2026.1792373 · 2026-03-05

## TL;DR

This study shows that combining two blood-based scores can help predict if early-stage cervical cancer patients will experience a recurrence after surgery.

## Contribution

The novel contribution is the development and validation of a combined SII-PNI score for predicting postoperative recurrence in cervical cancer.

## Key findings

- The combined SII-PNI score showed improved predictive performance with an AUC of 0.743.
- Higher SII-PNI scores were independently associated with increased recurrence risk after adjusting for covariates.
- Survival curves showed a graded increase in recurrence with rising SII-PNI scores.

## Abstract

Growing evidence suggests that immune-inflammatory status and nutritional condition influence cancer prognosis. In this study, a composite score combining the systemic immune ~ inflammation index (SII) and the prognostic nutritional index (PNI) was investigated for its ability to stratify the risk of postoperative recurrence in patients with early-stage cervical cancer (ESCC).

This multicenter, retrospective study enrolled 403 individuals diagnosed with early-stage cervical squamous cell carcinoma and treated with surgery performed with curative intent. Optimal SII and PNI cut-points were selected based on receiver operating characteristic (ROC) curve analysis and validated using internal bootstrapping (1,000 resamples). Disease-free survival was summarized with Kaplan ~ Meier analysis, whereas prognostic associations were quantified using a multivariable Cox proportional hazards model.

ROC-based analyses yielded cutoff values of 580.99 for SII and 49.81 for PNI, which were subsequently used for patient stratification. The combined SII - PNI score showed improved predictive performance compared to individual indices, with an area under the curve (AUC) of 0.743. Survival curves demonstrated a graded increase in postoperative recurrence with rising SII - PNI scores, and intergroup differences reached statistical significance (log-rank P < 0.001). After adjustment for relevant covariates, the combined SII - PNI score remained independently associated with recurrence risk following surgery.

Elevated SII - PNI scores were independently associated with an increased probability of postoperative recurrence among patients with early-stage cervical cancer. Although the discriminatory ability is moderate, this combined index holds promise as a cost-effective, complementary tool for refining risk stratification in this population.

## Linked entities

- **Diseases:** cervical cancer (MONDO:0002974), cervical squamous cell carcinoma (MONDO:0006143)

## Full-text entities

- **Diseases:** ESCC (MESH:D002583), inflammation (MESH:D007249), cervical squamous cell carcinoma (MESH:D002294), cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12999807/full.md

---
Source: https://tomesphere.com/paper/PMC12999807